Serum Institute of India fire: Five people killed, SII offers compensation of Rs 25 lakh to families; PM Narendra Modi condoles lives lost
Serum Institute of India (SII) has offered compensation of Rs 25 lakh in addition to the mandated amount to families of persons who died in a fire at the company's premises in Pune. Five men died after a fire broke out in a five-storeyed under-construction building at the firm's Manjari premises in Pune on Thursday. All were construction workers whose bodies were recovered by fire brigade personnel from the fifth floor..
Jan 21, 2021, 22:59 PM IST
Serum Institute of India fire: Five charred bodies recovered from building, says Pune mayor; Covishield facility not affected
The SII fire broke out where the BCG vaccine is made and the Covishield facility has not been affected, said, officials. So far, nine persons have been evacuated from the building in the SII's Manjari premises. There would be no loss of Covishield production due to the fire, Serum Institute of India CEO Adar Poonawalla said.
Jan 21, 2021, 18:39 PM IST
Massive fire breaks out at Terminal 1 gate of Pune's Serum Institute of India, 10 fire tenders rushed to spot
A massive fire broke out at the Serum Institute of India in Pune, Maharashtra, on Thursday (January 21). At least 10 fire tenders have reached the spot so far.
The fire broke out at Terminal 1 gate of the Manjari facility where the Covishield vaccine is being made. The Covishield vaccine is being used in the national inoculation drive against coronavirus.
Jan 21, 2021, 16:20 PM IST
Nepal approves emergency use of SII's Covishield
Nepal Government on Friday (January 15) approved the emergency use of 'Covishield' vaccine, which is being manufactured by the Serum Institute of India (SII).The decision for the usage of the vaccine was taken by the Department of Drug Administration (DDA).
Jan 15, 2021, 17:56 PM IST
Covishield: COVID-19 vaccine to be made available in private markets at Rs 1,000 after SII gets requisite permission, says CEO Adar Poonawalla
Adar Poonawalla stated that over 1.11 cr doses of Covishield vaccine are currently being rolled out across India.
Jan 12, 2021, 20:35 PM IST
We will have an amazing New Year Today, After Vaccination approval?
The approval for a Covid vaccine can come soon, the country's drugs control authority has indicated.
Jan 01, 2021, 12:06 PM IST
Pneumosil: India's first fully indigenous pneumococcal vaccine launched
The vaccine is developed by the Serum Institute of India (SII) in collaboration the Bill and Melinda Gates Foundation. Pneumococcal disease is a significant contributor to the under-five mortality rate worldwide.
Dec 29, 2020, 16:13 PM IST
Know all about Pneumosil, India's first indigenous pneumococcal vaccine
Pneumosil is being developed by Pune-based pharmaceutical company Serum Institute of India in collaboration with Bill and Melinda Gates Foundation.
Dec 29, 2020, 08:47 AM IST
COVID-19 vaccine: We will be producing around 300 mn doses by July 2021, says Adar Poonawalla of Serum Institute
Adar Poonawalla, Chief Executive Officer, Serum Institute of India, said, "We will be producing around 300 million doses by July 2021," adding "The first six months of 2021 will see a shortage globally."
Dec 28, 2020, 21:13 PM IST
Big breakthrough! Serum Institute of India develops first indigenous vaccine against pneumonia; launch next week
The vaccine will be much more affordable than existing ones manufactured by two foreign companies. India's drug regulator in July had granted market approval for the Pneumococcal Polysaccharide Conjugate vaccine, after reviewing the phase 1, 2 and 3 clinical trial data submitted by the Pune-based firm.
Dec 24, 2020, 07:46 AM IST
India requires Rs 80,000 cr for vaccine distribution next year: SII
The Central government plans to vaccinate nearly 30 crore people in the first phase of the drive. It will be offered to one crore healthcare workers, along with two crore frontline and essential workers and 27 crore elderly, mostly above the age of 50 years with comorbidities.
Dec 19, 2020, 13:24 PM IST
COVID-19 vaccine: Expert committee meeting to review claims of several companies
The expert committee will then submit its recommendations to the Drugs Controller General of India (DCGI) for emergency use authorisation for the COVID-19 vaccine.
Dec 08, 2020, 22:43 PM IST
Serum Institute of India seeks approval for emergency use of coronavirus vaccine
The Serum Institute of India (SII) in Pune has on Sunday applied to the Drugs Controller General of India (DCGI) for the emergency use authorisation of Oxford-AstraZeneca coronavirus vaccine in the country.
Dec 07, 2020, 09:04 AM IST
Corona Vaccine : Pfizer Seeks India Approval For Covid Vaccine
Pfizer has sought approval from the country's drug regulator - the DCGI (Drugs Controller General of India) - for emergency use authorization of its coronavirus vaccine.
Dec 06, 2020, 14:12 PM IST
Coronavirus Update : How will people get Corona Vaccine?
Experts believe that a COVID vaccine "will be ready in the next few weeks", Prime Minister Narendra Modi said. Watch the full Video.
Dec 05, 2020, 08:42 AM IST
COVID-19: Meet Adar Poonawala, the man behind Serum Institute of India developing Covishield vaccine
Adar Poonawalla joined the Serum Institute of India in 2001.
Dec 02, 2020, 11:12 AM IST
Covishield is 'safe and immunogenic', has no side effects, asserts Serum Institute of India
The vaccine candidate, Covishield, is being developed by the UK's Oxford University and US pharma giant AstraZeneca. The SII is a manufacturing partner for the vaccine.
Dec 01, 2020, 13:44 PM IST
SII rejects serious side effects of 'Covishield' vaccine claim by Chennai man; DCGI probes matter
The world's largest vaccine producer said it is evident that the intention behind the spreading of such malicious information is an oblique pecuniary motive.
Nov 29, 2020, 22:46 PM IST
PM Narendra Modi to interact with teams working on developing COVID-19 vaccine
The Prime Minister's Office informed that PM Modi will interact with the teams involved in developing COVID-19 vaccine via video conferencing on Monday.
Nov 29, 2020, 19:29 PM IST
PM Narendra Modi reviews COVID-19 vaccine work in Ahmedabad, Hyderabad and Pune, lauds researchers
PMO said that the PM's visit was aimed at getting a first-hand perspective of the COVID-19 vaccine preparations, challenges and roadmap in India's endeavour to vaccinate its citizens.
Nov 28, 2020, 18:46 PM IST
